中文 | English
Return
Total: 9 , 1/1
Show Home Prev Next End page: GO
Author:(Makoto SHIRAGAMI)

1.Introductory Teaching of Pharmacoeconomics in Pharmaceutical Education

Makoto SHIRAGAMI

Medical Education 2004;35(1):53-56

2.Pharmaceutical Sales and Frequency of Adverse Drug Reactions

Hironori Tsuchiya ; Yuka Onodera ; Makoto Shiragami

Japanese Journal of Drug Informatics 2011;13(2):44-46

3.Development of New Method for Post Marketing Surveillance (PMS) for Prescription-only to Over-The-Counter (OTC) Switch

Yuka Onodera ; Keiko Tokushige ; Makoto Shiragami

Japanese Journal of Drug Informatics 2012;14(2):58-61

4.Pharmacoeconomic Analysis of hyperlipidemia Treatment comparing Fibrate with Statin

Tsutomu Takahashi ; Yoshiyasu Saegusa ; Yukie Takimoto ; Makoto Shiragami

Japanese Journal of Drug Informatics 2009;11(2):96-101

5.Problems in Promotional Materials Created by Pharmaceutical Companies

Masato Komuro ; Keiichiro Orii ; Yuka Onodera ; Makoto Shiragami

Japanese Journal of Drug Informatics 2013;15(3):111-117

6.Development of Post Marketing Surveillance Method for Nonprescription Drugs Immediately after Rx-to-OTC Switch

Yuko Fujita ; Rie Nakajima ; Yuka Onodera ; Makoto Shiragami

Japanese Journal of Drug Informatics 2014;16(1):23-27

7.Feasibility Study for the Pharmacoeconomic Analysis of Kampo Medicines

Masayoshi KOINUMA ; Miwako KAMEI ; Kuniko MATSUMOTO ; Misai YAGI ; Makoto SHIRAGAMI

Kampo Medicine 2005;56(5):813-822

8.Meta-analysis on the Usefulness in Postpartum Control by Kyukichoketsuin with Methylergometrine Maleate as Control

Masayoshi KOINUMA ; Hitoshi NARIKAWA ; Miwako KAMEI ; Makoto SHIRAGAMI

Kampo Medicine 2006;57(1):45-55

9.Research on Community Resident’s Awareness and Needs for the Services Offered at Primary Care Pharmacies

Rie NAKAJIMA ; Makoto SHIRAGAMI

Japanese Journal of Social Pharmacy 2018;37(1):9-18

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 9 , 1/1 Show Home Prev Next End page: GO